Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Long noncoding RNAs (lncRNAs) are emerging regulators of periodontal inflammation. This study investigates the role of lncRNA MIR100HG in periodontitis and its interaction with the RNA-binding protein Quaking (QKI).

Methods: In vitro, human gingival fibroblasts (HGFs) were stimulated with Porphyromonas gingivalis lipopolysaccharide (Pg.LPS, 200 ng/mL, 24 h). In vivo, ligature-induced periodontitis was established in mice. RNA sequencing, RNA immunoprecipitation (RIP), fluorescence in situ hybridization (FISH), and Western blotting were employed to dissect molecular mechanisms.

Results: MIR100HG was downregulated in inflamed gingival tissues (RNA-seq). FISH and Subcellular RNA fractionation analysis confirmed MIR100HG was primarily localized in the nucleus of HGFs. Knockdown of MIR100HG attenuated Pg.LPS-stimulated inflammation (interleukin [IL]-1β, IL-6 and tumor necrosis factor alpha [TNF-α]) in HGFs, while overexpression exacerbated cytokine release. The interaction between QKI and MIR100HG was identified by RNA immunoprecipitation assays. QKI silencing reversed anti-inflammatory effects of MIR100HG knockdown, linking this axis to nuclear factor kappa B (NF-κB) activation. In mice, knockdown of MIR100HG significantly mitigated alveolar bone loss and the levels of inflammatory markers.

Conclusion: This study identifies MIR100HG as a key lncRNA in periodontitis, showing its downregulation in human and murine models. MIR100HG knockdown alleviates periodontal inflammation via a QKI-mediated feedback loop, underscoring its potential as a therapeutic target for periodontitis management.

Plain Language Summary: Long non-coding RNAs (lncRNAs) are emerging as critical regulators in the pathogenesis of periodontitis, yet the functional roles of most differentially expressed lncRNAs remain poorly understood. In this study, we identified MIR100HG as a significantly downregulated lncRNA in periodontitis-affected gingival tissues through RNA transcriptome sequencing. Functional experiments revealed that MIR100HG knockdown attenuates Porphyromonas gingivalis lipopolysaccharide (Pg.LPS) -induced inflammation in human gingival fibroblasts (HGFs), as evidenced by reduced levels of proinflammatory cytokines (interleukin [IL] -1β, IL-6, and tumor necrosis factor [TNF] -α), whereas MIR100HG overexpression exacerbates inflammatory responses. Mechanistically, MIR100HG activates the nuclear factor kappa B (NF-κB) signaling pathway by interacting with the RNA-binding protein Quaking (QKI), a known suppressor of NF-κB. This interaction forms a negative feedback loop that regulates inflammatory responses. Importantly, MIR100HG knockdown alleviated periodontal inflammation and bone loss in periodontitis mouse model, further supporting its pivotal role in disease progression. Our findings demonstrate that MIR100HG modulates periodontal inflammation through a QKI- mediated mechanism, highlighting its potential as a therapeutic target for periodontitis. This study provides novel insights into lncRNA-mediated immune regulation and highlights its potential as a therapeutic target for managing periodontitis.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jper.11394DOI Listing

Publication Analysis

Top Keywords

mir100hg
16
periodontal inflammation
16
mir100hg knockdown
16
rna-binding protein
12
protein quaking
12
potential therapeutic
12
therapeutic target
12
periodontitis
9
long noncoding
8
regulates inflammatory
8

Similar Publications

Background: Long noncoding RNAs (lncRNAs) are emerging regulators of periodontal inflammation. This study investigates the role of lncRNA MIR100HG in periodontitis and its interaction with the RNA-binding protein Quaking (QKI).

Methods: In vitro, human gingival fibroblasts (HGFs) were stimulated with Porphyromonas gingivalis lipopolysaccharide (Pg.

View Article and Find Full Text PDF

A novel MIR100HG transcript enhances tumorigenesis by inducing BCLAF1-mediated alternative splicing in colorectal cancer.

Cell Commun Signal

July 2025

National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, Jilin, 130012, China.

Background: Long non-coding RNAs (lncRNAs) play crucial roles in cancer pathogenesis, including colorectal cancer (CRC). Distinct lncRNA transcripts from the same gene show diverse regulatory roles in cancer. The MIR100HG, a lncRNA gene characterized by multiple transcript variants, has been implicated in promoting CRC oncogenesis.

View Article and Find Full Text PDF

SETD2, a frequently mutated epigenetic tumor suppressor gene in acute leukemia, is associated with chemotherapy resistance and poor patient outcomes. To explore potential therapeutics for SETD2-mutant leukemia, we employed an integrated approach combining computational prediction with epigenetic compound library screening. This approach identified G9a inhibitors as promising candidates, capable of reversing gene expression signatures associated with Setd2 deficiency and selectively inhibiting SETD2-deficient cells.

View Article and Find Full Text PDF

A LncRNA panel within EpCAM-specific exosomes for noninvasive early diagnosing non-small cell lung cancer.

Respir Res

April 2025

The Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510120, China.

Background: Plasma tumor-associated exosomes represent a promising source for cancer biomarkers; however, the role of long non-coding RNAs (lncRNAs) within these exosomes is not well-defined in non-small cell lung cancer (NSCLC).

Methods: We identified a panel of NSCLC-specific lncRNAs within plasma EpCAM-specific exosomes (Epexo) through a comparative analysis of lncRNA profiles between plasma Epexo and lung tissues. The panel's diagnostic value was firstly evaluated in a retrospective cohort of 210 NSCLC patients and 245 healthy controls, and validated in a prospective cohort of 192 patients with pulmonary nodules (nodule size < 3 cm in diameter).

View Article and Find Full Text PDF

RNA-sequencing: A reliable tool to unveil transcriptional landscape of paediatric B-other acute lymphoblastic leukaemia.

Br J Haematol

May 2025

Developmental Tumors Biology Group, Leukaemia and Paediatric Haematology Disorders, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu (IRSJD), Esplugues de Llobregat, Barcelona, Spain.

B-cell precursor acute lymphoblastic leukaemia (BCP-ALL) comprises multiple subtypes characterized by different genetic alterations. With the use of current standard-of-care tests used in clinical practice, 20%-30% of the cases may not be classified into the main genetic subtypes and additional approaches are needed. These patients are grouped in the heterogeneous category B-other ALL.

View Article and Find Full Text PDF